RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 1 filers reported holding RA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $24,673,000 | -50.0% | 513,937 | -51.1% | 0.01% | +20.0% |
Q4 2019 | $49,330,000 | +304.7% | 1,051,168 | +104.0% | 0.01% | +66.7% |
Q3 2019 | $12,188,000 | -9.3% | 515,377 | +15.3% | 0.00% | 0.0% |
Q2 2019 | $13,440,000 | +61.5% | 446,988 | +20.3% | 0.00% | +50.0% |
Q1 2019 | $8,321,000 | -25.7% | 371,488 | -39.6% | 0.00% | 0.0% |
Q4 2018 | $11,192,000 | +236.3% | 615,028 | +234.3% | 0.00% | +100.0% |
Q3 2018 | $3,328,000 | +130.0% | 183,975 | +26.5% | 0.00% | – |
Q2 2018 | $1,447,000 | +139.2% | 145,465 | +27.6% | 0.00% | – |
Q1 2018 | $605,000 | -15.4% | 114,037 | +35.4% | 0.00% | – |
Q4 2017 | $715,000 | -36.2% | 84,219 | +9.7% | 0.00% | – |
Q3 2017 | $1,121,000 | -20.4% | 76,784 | +2.2% | 0.00% | -100.0% |
Q2 2017 | $1,408,000 | -6.6% | 75,137 | +6.0% | 0.00% | 0.0% |
Q1 2017 | $1,508,000 | +52.0% | 70,863 | +8.5% | 0.00% | – |
Q4 2016 | $992,000 | – | 65,341 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |